[1] HONG W J,GUAN K L.The YAP and TAZ transcription co-activators:key downstream effectors of the mammalian Hippo pathway[J].Seminars in Cell & Developmental Biology,2012,23(7):785-793.
[2] MENG Z P,MOROISHI T,MOTTIER-PAVIE V,et al.MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway[J].Nature Communications,2015,6(1):8357.
[3] ZHANG L,TANG F Y,TERRACCIANO L,et al.NDR functions as a physiological YAP1 kinase in the intestinal epithelium[J].Current Biology,2015,25(3):296-305.
[4] LIN C W,YAO E,CHUANG P T.A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth[J].Developmental Biology,2015,403(1):101-113.
[5] LIU M,ZHAO S Y,LIN Q J,et al.YAP regulates the expression of
Hoxa1 and
Hoxc13 in mouse and human oral and skin epithelial tissues[J].Molecular and Cellular Biology,2015,35(8):1449-1461.
[6] NISHIO M,SUGIMACHI K,GOTO H,et al.Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice[J].Proceedings of the National Academy of Sciences of the United States of America,2016,113(1):E71-E80.
[7] WANG X H,FREIRE VALLS A, SCHERMANN G,et al.YAP/TAZ orchestrate VEGF signaling during developmental angiogenesis[J].Developmental Cell,2017,42(5):462-478.e7.
[8] JI S Y,LIU Q X,ZHANG S H,et al.FGF15 activates Hippo signaling to suppress bile acid metabolism and liver tumorigenesis[J].Developmental Cell,2019,48(4):460-474.e9.
[9] LITTLE D R,LYNCH A M,YAN Y,et al.Differential chromatin binding of the lung lineage transcription factor NKX2-1 resolves opposing murine alveolar cell fates in vivo[J].Nature Communications,2021,12(1):2509.
[10] KIM N G,GUMBINER B M.Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway[J].The Journal of Cell Biology,2015,210(3):503-515.
[11] XU X M,NIE J,LU L,et al.YAP-TEAD up-regulates
IRS2 expression to induce and deteriorate oesophageal cancer[J].Journal of Cellular and Molecular Medicine,2021,25(5):2584-2595.
[12] DRISKILL J H,ZHENG Y G,WU B K,et al.WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma[J].Genes & Development,2021,35(7/8):495-511.
[13] XIAO Q Q,QIAN Z L,ZHANG W Q,et al.Depletion of CABYR-a/b sensitizes lung cancer cells to TRAIL-induced apoptosis through YAP/p73-mediated DR5 upregulation[J].Oncotarget,2016,7(8):9513-9524.
[14] ZHAO R,FALLON T R,SALADI S V,et al.Yap tunes airway epithelial size and architecture by regulating the identity,maintenance,and self-renewal of stem cells[J].Developmental Cell,2014,30(2):151-165.
[15] GRVNDL M,WALZ S,HAUF L,et al.Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes[J].PLoS Genetics,2020,16(5):e1008818.
[16] MISKOLCZI Z,SMITH M P,ROWLING E J,et al.Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing[J].Oncogene,2018,37(23):3166-3182.
[17] ZHANG T Q,ZHANG K P,JI K Y,et al.MicroRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions[J].Cancer Cell International,2020,20(1):549.
[18] YING J,WANG P E,ZHANG S X,et al.Transforming growth factor-beta1 promotes articular cartilage repair through canonical Smad and Hippo pathways in bone mesenchymal stem cells[J].Life Sciences,2018,192:84-90.
[19] LI Q,SUN Y,JARUGUMILLI G K,et al.Lats1/2 sustain intestinal stem cells and Wnt activation through TEAD-dependent and independent transcription[J].Cell Stem Cell,2020,26(5):675-692.e8.
[20] SHAH S R,DAVID J M,TIPPENS N D,et al.Brachyury-YAP regulatory axis drives stemness and growth in cancer[J].Cell Reports,2017,21(2):495-507.
[21] SZETO S G,NARIMATSU M,LU M L,et al.YAP/TAZ are mechanoregulators of TGF-β-Smad signaling and renal fibrogenesis[J].Journal of the American Society of Nephrology,2016,27(10):3117-3128.
[22] KOINIS F,CORN P,PARIKH N,et al.Resistance to MET/VEGFR2 inhibition by cabozantinib is mediated by YAP/TBX5-dependent induction of FGFR1 in castration-resistant prostate cancer[J].Cancers,2020,12(1):244.
[23] WEI W,XUE L L,TAN L Y,et al.Inhibition of yes-associated protein dephosphorylation prevents aggravated periodontitis with occlusal trauma[J].Journal of Periodontology,2021,92(7):1036-1048.
[24] MCGINN J,HALLOU A,HAN S,et al.A biomechanical switch regulates the transition towards homeostasis in oesophageal epithelium[J].Nature Cell Biology,2021,23(5):511-525.
[25] SHAO D,ZHAI P Y,DEL RE D P,et al.A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response[J].Nature Communications,2014,5:3315.
[26] YUAN F,WANG J L,LI R X,et al.A new regulatory mechanism between P53 and YAP crosstalk by SIRT1 mediated deacetylation to regulate cell cycle and apoptosis in A549 cell lines[J].Cancer Management and Research,2019,11:8619-8633.
[27] MOHSENI M,SUN J L,LAU A,et al.A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway[J].Nature Cell Biology,2014,16(1):108-117.
[28] YU J Z,ZHENG Y G,DONG J X,et al.Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded[J].Developmental Cell,2010,18(2):288-299.
[29] LING C,ZHENG Y G,YIN F,et al.The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to expanded[J].Proceedings of the National Academy of Sciences of the United States of America,2010,107(23):10532-10537.
[30] MATSUDA T,ZHAI P Y,SCIARRETTA S,et al.NF2 activates Hippo signaling and promotes ischemia/reperfusion injury in the heart[J].Circulation Research,2016,119(5):596-606.
[31] FANG C Y,LAI T C,HSIAO M,et al.The diverse roles of TAO kinases in health and diseases[J].International Journal of Molecular Sciences,2020,21(20):7463.
[32] WILSON K E,LI Y W,YANG N,et al.PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function[J].The Journal of Biological Chemistry,2014,289(34):23693-23700.
[33] YUAN L S,MAO Y,LUO W,et al.Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism[J].The Journal of Biological Chemistry,2017,292(36):15002-15015.
[34] BAE S J,NI L S,LUO X L.STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism[J].eLife,2020,9:e54863.
[35] SEO G,HAN H,VARGAS R E,et al.MAP4K interactome reveals STRN4 as a key STRIPAK complex component in Hippo pathway regulation[J].Cell Reports,2020,32(1):107860.
[36] ZHANG Y L,LI Q,YANG X M,et al.SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin-Rho GTPase-Hippo pathways[J].Cancer Research,2018,78(9):2305-2317.
[37] IBAR C,IRVINE K D.Integration of Hippo-YAP signaling with metabolism[J].Developmental Cell,2020,54(2):256-267.
[38] YE J,LI T S,XU G,et al.JCAD promotes progression of nonalcoholic steatohepatitis to liver cancer by inhibiting LATS2 kinase activity[J].Cancer Research,2017,77(19):5287-5300.
[39] SHIELDS C E,POTLAPALLI S,CUYA-SMITH S M,et al.Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target[J].Molecular Oncology,2021,15(8):2156-2171.
[40] HABBIG S,BARTRAM M P,MVLLER R U,et al.NPHP4,a cilia-associated protein,negatively regulates the Hippo pathway[J].The Journal of Cell Biology,2011,193(4):633-642.
[41] ZHENG X,CHEN L J,ZHOU Y,et al.A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling[J].Molecular Cancer,2019,18(1):47.
[42] WEHR M C,HOLDER M V,GAILITE I,et al.Salt-inducible kinases regulate growth through the Hippo signalling pathway in
Drosophila[J].Nature Cell Biology,2013,15(1):61-71.
[43] IWASA H,HOSSAIN S,HATA Y.Tumor suppressor C-RASSF proteins[J].Cellular and Molecular Life Sciences,2018,75(10):1773-1787.
[44] AZAD T,NOURI K,JANSE VAN RENSBURG H J,et al.A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis[J].Oncogene,2020,39(2):334-355.
[45] YU F X,ZHAO B,PANUPINTHU N,et al.Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling[J].Cell,2012,150(4):780-791.
[46] MA Y W,WANG L H,HE F L,et al.LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction[J].Cancer Letters,2021,506:67-82.
[47] HUANG S S,CAO Y,GUO H,et al.Up-regulated acylglycerol kinase (
AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop[J].Journal of Cellular and Molecular Medicine,2020,24(19):11133-11145.
[48] HUANG Z H,SUN D,HU J X,et al.Neogenin promotes BMP2 activation of YAP and Smad1 and enhances astrocytic differentiation in developing mouse neocortex[J].Journal of Neuroscience,2016,36(21):5833-5849.
[49] PULKKINEN H H,KIEMA M,LAPPALAINEN J P,et al.BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF[J].Angiogenesis,2021,24(1):129-144.
[50] KIM J,KWON H,SHIN Y K,et al.MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis[J].Proceedings of the National Academy of Sciences of the United States of America,2020,117(24):13529-13540.
[51] VERMA N K,GADI A,MAURIZI G,et al.Myeloid zinc finger 1 and GA binding protein co-operate with Sox2 in regulating the expression of yes-associated protein 1 in cancer cells[J].Stem Cells,2017,35(12):2340-2350.
[52] MIAO J B,KYOYAMA H,LIU L W,et al.Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells[J].Journal of Cellular and Molecular Medicine,2020,24(1):1087-1098.
[53] GONZÁLEZ-MARISCAL L,GALLEGO-GUTIÉRREZ H,GONZÁLEZ-GONZÁLEZ L,et al.ZO-2 is a master regulator of gene expression,cell proliferation,cytoarchitecture,and cell size[J].International Journal of Molecular Sciences,2019,20(17):4128.
[54] CAI X M,WANG K C,MENG Z P.Mechanoregulation of YAP and TAZ in cellular homeostasis and disease progression[J].Frontiers in Cell and Developmental Biology,2021,9:673599.
[55] DENG H,WANG W,YU J Z,et al.Spectrin regulates Hippo signaling by modulating cortical actomyosin activity[J].eLife,2015,4:e06567.
[56] FLETCHER G C,ELBEDIWY A,KHANAL I,et al.The spectrin cytoskeleton regulates the hippo signalling pathway[J].The EMBO Journal,2015,34(7):940-954.
[57] NAWAZ Z,PATIL V,ARORA A,et al.Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription[J].Scientific Reports,2016,6(1):27753.
[58] LEE J S,PARK H W,CHO K J,et al.Sestrin2 inhibits YAP activation and negatively regulates corneal epithelial cell proliferation[J].Experimental & Molecular Medicine,2020,52(6):951-962.
[59] JIAO S,WANG H Z,SHI Z B,et al.A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer[J].Cancer Cell,2014,25(2):166-180.
[60] CLARKE L E,COOK A,MATHAVARAJAH S,et al.Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition[J].FASEB Journal,2021,35(11):e22001.
[61] JIA L L,ZHANG Y P,JI Y W,et al.YAP balances the osteogenic and adipogenic differentiation of hPDLSCs
in vitro partly through the Wnt/β-catenin signaling pathway[J].Biochemical and Biophysical Research Communications,2019,518(1):154-160.
[62] ZHOU D W,CONRAD C,XIA F,et al.Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene[J].Cancer Cell,2009,16(5):425-438.
[63] LEE J H,KIM T S,YANG T H,et al.A crucial role of WW45 in developing epithelial tissues in the mouse[J].The EMBO Journal,2008,27(8):1231-1242.
[64] NISHIO M,HAMADA K,KAWAHARA K,et al.Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice[J].The Journal of Clinical Investigation,2012,122(12):4505-4518.
[65] SINGH K,PRUSKI M A,POLIREDDY K,et al.Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer[J].Oncogene,2020,39(5):1152-1164.
[66] LI W L,DENG Y J,FENG B,et al.Mst1/2 kinases modulate glucose uptake for osteoblast differentiation and bone formation[J].Journal of Bone and Mineral Research,2018,33(6):1183-1195.
[67] DENG Y J,LU J Q,LI W L,et al.Reciprocal inhibition of YAP/TAZ and NF-κB regulates osteoarthritic cartilage degradation[J].Nature Communications,2018,9(1):4564.
[68] MENG C L,TIAN G,XU C H,et al.Hippo kinases MST1 and MST2 control the differentiation of the epididymal initial segment via the MEK-ERK pathway[J].Cell Death and Differentiation,2020,27(10):2797-2809.
[69] WANG P,GENG J,GAO J H,et al.Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis[J].Nature Communications,2019,10(1):755.
[70] LEUNG J Y,WILSON H L,VOLTZKE K J,et al.Sav1 loss induces senescence and Stat3 activation coinciding with tubulointerstitial fibrosis[J].Molecular and Cellular Biology,2017,37(12):e00565-16.
[71] KAI T,TSUKAMOTO Y,HIJIYA N,et al.Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway[J].The Journal of Pathology,2016,239(1):97-108.
[72] JEONG S H,KIM H B,KIM M C,et al.Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer[J].The Journal of Clinical Investigation,2018,128(3):1010-1025.
[73] TAMURA T,KODAMA T,SATO K,et al.Dysregulation of PI3K and hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation[J].The Journal of Clinical Investigation,2021,131(13):143414.
[74] ZHANG X Y,GUO C,WU X W,et al.Analysis of liver tumor-prone mouse models of the hippo kinase scaffold proteins RASSF1A and SAV1[J].Cancer Research,2016,76(9):2824-2835.
[75] COTTON J L,LI Q,MA L F,et al.YAP/TAZ and hedgehog coordinate growth and patterning in gastrointestinal mesenchyme[J].Developmental Cell,2017,43(1):35-47.e4.
[76] GUILLERMIN O,ANGELIS N,SIDOR C M,et al.Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration[J].The EMBO Journal,2021,40(13):e105770.
[77] HONG S P,YANG M J,CHO H,et al.Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi[J].Nature Communications,2020,11(1):4102.
[78] CHEUNG P,XIOL J,DILL M T,et al.Regenerative reprogramming of the intestinal stem cell state via Hippo signaling suppresses metastatic colorectal cancer[J].Cell Stem Cell,2020,27(4):590-604.e9.
[79] WU L M N,DENG Y Q,WANG J C,et al.Programming of Schwann cells by Lats1/2-TAZ/YAP signaling drives malignant peripheral nerve sheath tumorigenesis[J].Cancer Cell,2018,33(2):292-308.e7.
[80] CHEN Z G,LI S,MO J,et al.Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling[J].JCI Insight,2020,5(20):e141514.
[81] NANTIE L B,YOUNG R E,PALTZER W G,et al.Lats1/2 inactivation reveals Hippo function in alveolar type Ⅰ cell differentiation during lung transition to air breathing[J].Development,2018,145(21):dev163105.
[82] PARK J,KIM J S,NAHM J H,et al.WWC1 and NF2 prevent the development of intrahepatic cholangiocarcinoma by regulating YAP/TAZ activity through LATS in mice[J].Molecules and Cells,2020,43(5):491-499.
[83] XIAO Y,HILL M C,LI L L,et al.Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis[J].Genes & Development,2019,33(21/22):1491-1505.
[84] BAE J S,JEON Y,KIM S M,et al.Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling[J].Cell Death & Disease,2018,9(11):1083.
[85] OMORI H,NISHIO M,MASUDA M,et al.YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma[J].Science Advances,2020,6(12):eaay3324.
[86] OTSUBO K,GOTO H,NISHIO M,et al.MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation,adhesion and tumour formation[J].Oncogene,2017,36(29):4201-4211.
[87] GOTO H,NISHIO M,TO Y,et al.Loss of Mob1a/b in mice results in chondrodysplasia due to YAP1/TAZ-TEAD-dependent repression of SOX9[J].Development,2018,145(6):dev159244.
[88] XIN M,KIM Y,SUTHERLAND L B,et al.Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size[J].Science Signaling,2011,4(196):ra70.
[89] XIN M,KIM Y,SUTHERLAND L B,et al.Hippo pathway effector Yap promotes cardiac regeneration[J].Proceedings of the National Academy of Sciences of the United States of America,2013,110(34):13839-13844.
[90] BYUN J,DEL RE D P,ZHAI P Y,et al.Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload[J].The Journal of Biological Chemistry,2019,294(10):3603-3617.
[91] ISAGO H,MITANI A,MIKAMI Y,et al.Epithelial expression of
YAP and
TAZ is sequentially required in lung development[J].American Journal of Respiratory Cell and Molecular Biology,2020,62(2):256-266.
[92] AI L Q Y,YUAN R D,CHEN X,et al.Retinal blood vessel-origin yes-associated protein (YAP) governs astrocytic maturation via leukaemia inhibitory factor (LIF)[J].Cell Proliferation,2020,53(2):e12757.
[93] DAI Y J,HAO P,SUN Z M,et al.Liver knockout
YAP gene improved insulin resistance-induced hepatic fibrosis[J].Journal of Endocrinology,2021,249(2):149-161.
[94] LEE Y A,NOON L A,AKAT K M,et al.Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap[J].Nature Communications,2018,9(1):4962.
[95] ZHAO K,SHEN C Y,LU Y S,et al.Muscle Yap is a regulator of neuromuscular junction formation and regeneration[J].Journal of Neuroscience,2017,37(13):3465-3477.
[96] HUANG Z H,HU J X,PAN J X,et al.YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation[J].Development,2016,143(13):2398-2409.
[97] LACANNA R,LICCARDO D,ZHANG P,et al.Yap/Taz regulate alveolar regeneration and resolution of lung inflammation[J].The Journal of Clinical Investigation,2019,129(5):2107-2122.
[98] VANYAI H K,PRIN F,GUILLERMIN O,et al.Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway[J].Development,2020,147(21):dev187187.
[99] MIA M M,CIBI D M,BINTE ABDUL GHANI S A,et al.Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodeling and improves cardiac function[J/OL].Cardiovascular Research,2021:cvab205.(2021-06-16)[2021-06-16].https://pubmed.ncbi.nlm.nih.gov/34132780.DOI:10.1093/cvr/cvab205.
[100] MIA M M,CIBI D M,ABDUL GHANI S A B,et al.YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction[J].PLoS Biology,2020,18(12):e3000941.
[101] LIU W A,CHEN S,LI Z Z,et al.PARD3 dysfunction in conjunction with dynamic HIPPO signaling drives cortical enlargement with massive heterotopia[J].Genes & Development,2018,32(11/12):763-780.
[102] OKUYAMA M,JIANG W H,YANG L H,et al.Mst1/2 kinases inhibitor,XMU-MP-1,attenuates angiotensin Ⅱ-induced ascending aortic expansion in hypercholesterolemic mice[J].Circulation Reports,2021,3(5):259-266.
[103] BASU D,LETTAN R,DAMODARAN K,et al.Identification,mechanism of action,and antitumor activity of a small molecule inhibitor of Hippo,TGF-β,and Wnt signaling pathways[J].Molecular Cancer Therapeutics,2014,13(6):1457-1467.
[104] TANG Y,FANG G M,GUO F H,et al.Selective inhibition of STRN3-containing PP2A phosphatase restores Hippo tumor-suppressor activity in gastric cancer[J].Cancer Cell,2020,38(1):115-128.e9.
[105] SONG J,GAO Q L,WU B W,et al.Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents
in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway[J].European Journal of Medicinal Chemistry,2020,203:112618.
[106] WANG Q,LU P,WANG T,et al.Sitagliptin affects gastric cancer cells proliferation by suppressing melanoma-associated antigen-A3 expression through yes-associated protein inactivation[J].Cancer Medicine,2020,9(11):3816-3828.
[107] ZHAO S,XU K,JIANG R,et al.Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-associated protein signaling pathway[J].Life Sciences,2020,251:117424.
[108] YE C M,WANG W Q,XIA G J,et al.A novel curcumin derivative CL-6 exerts antitumor effect in human gastric cancer cells by inducing apoptosis through Hippo-YAP signaling pathway[J].OncoTargets and Therapy,2019,12:2259-2269.
[109] DENT P,BOOTH L,ROBERTS J L,et al.Neratinib inhibits Hippo/YAP signaling,reduces mutant K-RAS expression,and kills pancreatic and blood cancer cells[J].Oncogene,2019,38(30):5890-5904.
[110] DONG W H,DONG Q,DING H R.Ophiopogonin B induces reactive oxygen species dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma[J].Molecular Medicine Reports,2021,24(1):534.
[111] CHAI Y T,XIANG K,WU Y Z,et al.Cucurbitacin B inhibits the Hippo-YAP signaling pathway and exerts anticancer activity in colorectal cancer cells[J].Medical Science Monitor,2018,24:9251-9258.
[112] LIU J,LI J,CHEN H,et al.Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway[J].Journal of Cellular and Molecular Medicine,2020,24(10):5786-5796.
[113] WANG H N,WANG R,HUANG D,et al.Homoharringtonine exerts anti-tumor effects in hepatocellular carcinoma through activation of the Hippo pathway[J].Frontiers in Pharmacology,2021,12:592071.
[114] TAN S J,ZHAO Z,QIAO Y N,et al.Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis[J].Biochemical Pharmacology,2021,185:114423.
[115] TAO L C,CHEN X,ZHENG Y F,et al.Chinese propolis suppressed pancreatic cancer Panc-1 cells proliferation and migration via Hippo-YAP pathway[J].Molecules,2021,26(9):2803.
[116] WANG W S,HUANG Q J,CHEN Y,et al.The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation[J].Pharmacological Research,2021,170:105723.
[117] JIAO T Y,YAO X P,ZHAO Y Y,et al.Dexamethasone-induced liver enlargement is related to PXR/YAP activation and lipid accumulation but not hepatocyte proliferation[J].Drug Metabolism and Disposition,2020,48(9):830-839.
[118] WANG C,ZHU X Y,FENG W W,et al.Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm[J].American Journal of Cancer Research,2016,6(1):27-37.
[119] LI Y J,LU J,CHEN Q,et al.Artemisinin suppresses hepatocellular carcinoma cell growth,migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling[J].Archives of Toxicology,2019,93(11):3367-3383.
[120] FU W W,ZHAO P,LI H,et al.Bazedoxifene enhances paclitaxel efficacy to suppress glioblastoma via altering Hippo/YAP pathway[J].Journal of Cancer,2020,11(3):657-667.
[121] JI X Y,SONG L H,SHENG L,et al.Cyclopeptide RA-V inhibits organ enlargement and tumorigenesis induced by YAP activation[J].Cancers,2018,10(11):449.
[122] WANG Z Y,WU Y P,WANG H F,et al.Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility[J].Proceedings of the National Academy of Sciences of the United States of America,2014,111(1):E89-E98.
[123] LIU D D,LYU H,LIU Q,et al.Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow[J].Journal of Translational Medicine,2019,17(1):378.
[124] CHENG Y,CHEN T Y,CHEN J J.Erzhu Jiedu decoction ameliorates liver precancerous lesions in a rat model of liver cancer[J].Journal of Cancer,2020,11(24):7302-7311.
[125] SONG S M,XIE M,SCOTT A W,et al.A novel YAP1 inhibitor targets CSC-enriched radiation-resistant cells and exerts strong antitumor activity in esophageal adenocarcinoma[J].Molecular Cancer Therapeutics,2018,17(2):443-454.
[126] CHAO Y C,LEE K Y,WU S M,et al.Melatonin downregulates
PD-
L1 expression and modulates tumor immunity in KRAS-mutant non-small cell lung cancer[J].International Journal of Molecular Sciences,2021,22(11):5649.
[127] SAUNDERS J T,HOLMES B,BENAVIDES-SERRATO A,et al.Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma[J].Journal of Neuro-Oncology,2021,152(2):217-231.
[128] LORTHONGPANICH C,CHAROENWONGPAIBOON T,SUPAKUN P,et al.Fisetin inhibits osteogenic differentiation of mesenchymal stem cells via the inhibition of YAP[J].Antioxidants,2021,10(6):879.
[129] MÉLIN L,ABDULLAYEV S,FNAICHE A,et al.Development of LM98,a small-molecule TEAD inhibitor derived from flufenamic acid[J].ChemMedChem,2021,16(19):2982-3002.
[130] SMITH S A,SESSIONS R B,SHOEMARK D K,et al.Antiproliferative and antimigratory effects of a novel YAP-TEAD interaction inhibitor identified using
in silico molecular docking[J].Journal of Medicinal Chemistry,2019,62(3):1291-1305.
[131] KIM S H,JIN H,MENG R Y,et al.Activating Hippo pathway via Rassf1 by ursolic acid suppresses the tumorigenesis of gastric cancer[J].International Journal of Molecular Sciences,2019,20(19):4709.
[132] XUE M L,LIANG H,JI X Q,et al.Effects of fucoidan on gut flora and tumor prevention in 1,2-dimethylhydrazine-induced colorectal carcinogenesis[J].The Journal of Nutritional Biochemistry,2020,82:108396.
[133] ZHENG Y Z,YANG X P,TAN J,et al.Curcumin suppresses the stemness of non-small cell lung cancer cells via promoting the nuclear-cytoplasm translocation of TAZ[J].Environmental Toxicology,2021,36(6):1135-1142.
[134] GAO Y,SHI Q,XU S,et al.Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells[J].International Journal of Molecular Sciences,2014,15(9):15173-15187.
[135] WANG Z L,XING W,SONG Y L,et al.Folic acid has a protective effect on retinal vascular endothelial cells against high glucose[J].Molecules,2018,23(9):2326.
[136] HONG L,ZHA Y J,WANG C,et al.Folic acid alleviates high glucose and fat-induced pyroptosis via inhibition of the Hippo signal pathway on H9C2 cells[J].Frontiers in Molecular Biosciences,2021,8:698698.
[137] TRUJILLO-GONZALEZ I,FRIDAY W B,MUNSON C A,et al.Low availability of choline
in utero disrupts development and function of the retina[J].FASEB Journal,2019,33(8):9194-9209.
[138] WANG Z H,LI L,GU W W,et al.Resveratrol reverses osteogenic decline of bone marrow mesenchymal stem cells via upregulation of
YAP expression in inflammatory environment[J].Stem Cells and Development,2021,30(24):1202-1214.
[139] KIM Y N,CHOE S R,CHO K H,et al.Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis[J].Experimental & Molecular Medicine,2017,49(2):e296.
[140] XU G R,CHEN J Z,WANG G R,et al.Resveratrol inhibits the tumorigenesis of follicular thyroid cancer via ST6GAL2-regulated activation of the Hippo signaling pathway[J].Molecular Therapy Oncolytics,2020,16:124-133.
[141] JIANG Z D,CHEN X,CHEN K,et al.YAP inhibition by resveratrol via activation of AMPK enhances the sensitivity of pancreatic cancer cells to gemcitabine[J].Nutrients,2016,8(10):546.
[142] LI C X,ZHANG R R,ZHAN Y T,et al.Resveratrol inhibits hepatic stellate cell activation via the Hippo pathway[J].Mediators of Inflammation,2021,2021:3399357.
京公网安备 11010802041926号